Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
Active & Responsive
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
for
Decision Making, Shared, Family Caregiving,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT06173323
Recruiting
A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines
for
Upper Facial Lines, Glabellar Lines
Location: Birmingham AL, Atlanta GA, Nashville TN, New Orleans LA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07871513
Phase 2, Recruiting
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
for
Hidradenitis Suppurativa
Location: Birmingham AL, North Little Rock AR, New Albany IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07665437
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Location: Birmingham AL, Murfreesboro TN, Macon GA, Charlotte NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Birmingham AL, Columbus MS, Atlanta GA, New Albany MS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Birmingham AL, Atlanta GA, Pensacola FL, Paducah KY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Birmingham AL, Atlanta GA, Nashville TN, New Orleans LA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Birmingham AL, Atlanta GA, Nashville TN, Memphis TN,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Birmingham AL, Tallahassee FL, New Orleans LA,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Birmingham AL, Cincinnati OH, Charlottesville VA,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07593391
Phase 3, Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Birmingham AL, Newnan GA, Marietta GA, Jackson TN,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase 3, Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
for
Indolent Systemic Mastocytosis,
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Durham NC,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT04910685
Phase 2, Phase 3, Recruiting
State of Hormones Impact Nociceptive Expression
for
Pain, Gender Identity
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 65
Code: NCT05787470
Recruiting
Remote Ischemic Conditioning Using the autoRIC
for
Ischemia-Reperfusion Injury
Location: Birmingham AL, Charlotte NC, Jacksonville FL,
Sponsor: CellAegis US, Inc.
Sex: All
Age: 18+
Code: NCT03318575
Recruiting
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
for
Cardiometabolic Risk Factors in Adult Wheelchair Users
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05606432
Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: Birmingham AL, Atlanta GA, Saint Louis MO, Columbus OH,
Sponsor: TopAlliance Biosciences
Sex: All
Age: 18+
Code: NCT04137900
Phase 1, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors